HHS, DOD Collaborate With Regeneron on Large-Scale Manufacturing Demonstration Project of COVID-19 Investigational Therapeutic Treatment
July 08, 2020
July 08, 2020
WASHINGTON, July 8 -- The U.S. Department of Health and Human Services issued the following news release:
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD exit disclaimer icon) announced an agreement with Regeneron, Inc. of Tarrytown, New York, to demonstrate commercial-scale manufacturing of the company's COVID-19 investigational anti-viral antibody treatment, REGN-COV2. By funding this manufacturing effort, the federal government will own the d . . .
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD exit disclaimer icon) announced an agreement with Regeneron, Inc. of Tarrytown, New York, to demonstrate commercial-scale manufacturing of the company's COVID-19 investigational anti-viral antibody treatment, REGN-COV2. By funding this manufacturing effort, the federal government will own the d . . .